Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

Misganaw Asmamaw Mengstie,Muluken Teshome Azezew,Tadesse Asmamaw Dejenie,Assefa Agegnehu Teshome,Fitalew Tadele Admasu,Awgichew Behaile Teklemariam,Anemut Tilahun Mulu,Melaku Mekonnen Agidew,Dagnew Getnet Adugna,Habtamu Geremew,Endeshaw Chekol Abebe
DOI: https://doi.org/10.2147/BTT.S429411
2024-01-18
Biologics
Abstract:The CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)) and the associated protein (Cas9) system, a young but well-studied genome-editing tool, holds plausible solutions to a wide range of genetic disorders. The single-guide RNA (sgRNA) with a 20-base user-defined spacer sequence and the Cas9 endonuclease form the core of the CRISPR-Cas9 system. This sgRNA can direct the Cas9 nuclease to any genomic region that includes a protospacer adjacent motif (PAM) just downstream and matches the spacer sequence. The current challenge in the clinical applications of CRISPR-Cas9 genome-editing technology is the potential off-target effects that can cause DNA cleavage at the incorrect sites. Off-target genome editing confuses and diminishes the therapeutic potential of CRISPR-Cas9 in addition to potentially casting doubt on scientific findings regarding the activities of genes. In this review, we summarize the recent technological advancements in reducing the off-target effect of CRISPR-Cas9 genome editing.
What problem does this paper attempt to address?